Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern Argentina

Autores
Niborski, Leticia Laura; Grippo, Vanina; Lafon, Sonia Olga; Levitus, Gabriela Laura; García Bournissen, Facundo; Ramirez Gomez, Juan Carlos; Burgos, Juan Miguel; Bisio, Margarita María Catalina; Juiz, Natalia Anahí; Ayala, Vilma; Coppede, María; Herrera, Verónica; López, Crescencia; Contreras, Ana; Gomez, Karina Andrea; Elean, Juan C.; Mujica, Hugo D.; Schijman, Alejandro Gabriel; Levin, Mariano Jorge; Longhi, Silvia Andrea
Año de publicación
2016
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
This study aimed to evaluate well-documented diagnostic antigens, named B13, 1F8 and JL7 recombinant proteins, as potential markers of seroconversion in treated chagasic patients. Prospective study, involving 203 patients treated with benznidazole, was conducted from endemic areas of northern Argentina. Follow-up was possible in 107 out of them and blood samples were taken for serology and PCR assays before and 2, 3, 6, 12, 24 and 36 months after treatment initiation. Reactivity against Trypanosoma cruzi lysate and recombinant antigens was measured by ELISA. The rate of decrease of antibody titers showed nonlinear kinetics with an abrupt drop within the first three months after initiation of treatment for all studied antigens, followed by a plateau displaying a low decay until the end of follow-up. At this point, anti-B13, anti-1F8 and anti-JL7 titers were relatively close to the cut-off line, while anti-T. cruzi antibodies still remained positive. At baseline, 60.8% (45/74) of analysed patients tested positive for parasite DNA by PCR and during the follow-up period in 34 out of 45 positive samples (75.5%) could not be detected T. cruzi DNA. Our results suggest that these antigens might be useful as early markers for monitoring antiparasitic treatment in chronic Chagas disease.
Fil: Niborski, Leticia Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Grippo, Vanina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Lafon, Sonia Olga. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Levitus, Gabriela Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: García Bournissen, Facundo. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Ramirez Gomez, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Burgos, Juan Miguel. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Bisio, Margarita María Catalina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Juiz, Natalia Anahí. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Ayala, Vilma. Centro Asistencial Cáritas Diocesana; Argentina
Fil: Coppede, María. Centro Asistencial Cáritas Diocesana; Argentina
Fil: Herrera, Verónica. Centro Asistencial Cáritas Diocesana; Argentina
Fil: López, Crescencia. Centro Asistencial Cáritas Diocesana; Argentina
Fil: Contreras, Ana. Centro Asistencial Cáritas Diocesana; Argentina
Fil: Gomez, Karina Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Elean, Juan C.. Centro Asistencial Cáritas Diocesana; Argentina
Fil: Mujica, Hugo D.. Centro Asistencial Cáritas Diocesana; Argentina. Hospital Zonal de Añatuya; Argentina
Fil: Schijman, Alejandro Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Levin, Mariano Jorge. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Longhi, Silvia Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Materia
ADVERSE EFFECTS
BENZNIDAZOLE TREATMENT
CHRONIC CHAGAS DISEASE
SEROLOGICAL FOLLOW-UP
TRYPANOSOMA CRUZI
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/114690

id CONICETDig_fa849a78d674fb55660b1c518f9b6385
oai_identifier_str oai:ri.conicet.gov.ar:11336/114690
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern ArgentinaNiborski, Leticia LauraGrippo, VaninaLafon, Sonia OlgaLevitus, Gabriela LauraGarcía Bournissen, FacundoRamirez Gomez, Juan CarlosBurgos, Juan MiguelBisio, Margarita María CatalinaJuiz, Natalia AnahíAyala, VilmaCoppede, MaríaHerrera, VerónicaLópez, CrescenciaContreras, AnaGomez, Karina AndreaElean, Juan C.Mujica, Hugo D.Schijman, Alejandro GabrielLevin, Mariano JorgeLonghi, Silvia AndreaADVERSE EFFECTSBENZNIDAZOLE TREATMENTCHRONIC CHAGAS DISEASESEROLOGICAL FOLLOW-UPTRYPANOSOMA CRUZIhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3This study aimed to evaluate well-documented diagnostic antigens, named B13, 1F8 and JL7 recombinant proteins, as potential markers of seroconversion in treated chagasic patients. Prospective study, involving 203 patients treated with benznidazole, was conducted from endemic areas of northern Argentina. Follow-up was possible in 107 out of them and blood samples were taken for serology and PCR assays before and 2, 3, 6, 12, 24 and 36 months after treatment initiation. Reactivity against Trypanosoma cruzi lysate and recombinant antigens was measured by ELISA. The rate of decrease of antibody titers showed nonlinear kinetics with an abrupt drop within the first three months after initiation of treatment for all studied antigens, followed by a plateau displaying a low decay until the end of follow-up. At this point, anti-B13, anti-1F8 and anti-JL7 titers were relatively close to the cut-off line, while anti-T. cruzi antibodies still remained positive. At baseline, 60.8% (45/74) of analysed patients tested positive for parasite DNA by PCR and during the follow-up period in 34 out of 45 positive samples (75.5%) could not be detected T. cruzi DNA. Our results suggest that these antigens might be useful as early markers for monitoring antiparasitic treatment in chronic Chagas disease.Fil: Niborski, Leticia Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: Grippo, Vanina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: Lafon, Sonia Olga. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: Levitus, Gabriela Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: García Bournissen, Facundo. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Ramirez Gomez, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: Burgos, Juan Miguel. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: Bisio, Margarita María Catalina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: Juiz, Natalia Anahí. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: Ayala, Vilma. Centro Asistencial Cáritas Diocesana; ArgentinaFil: Coppede, María. Centro Asistencial Cáritas Diocesana; ArgentinaFil: Herrera, Verónica. Centro Asistencial Cáritas Diocesana; ArgentinaFil: López, Crescencia. Centro Asistencial Cáritas Diocesana; ArgentinaFil: Contreras, Ana. Centro Asistencial Cáritas Diocesana; ArgentinaFil: Gomez, Karina Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: Elean, Juan C.. Centro Asistencial Cáritas Diocesana; ArgentinaFil: Mujica, Hugo D.. Centro Asistencial Cáritas Diocesana; Argentina. Hospital Zonal de Añatuya; ArgentinaFil: Schijman, Alejandro Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: Levin, Mariano Jorge. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFil: Longhi, Silvia Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; ArgentinaFundação Oswaldo Cruz2016-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/114690Niborski, Leticia Laura; Grippo, Vanina; Lafon, Sonia Olga; Levitus, Gabriela Laura; García Bournissen, Facundo; et al.; Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern Argentina; Fundação Oswaldo Cruz; Memórias do Instituto Oswaldo Cruz; 111; 6; 6-2016; 365-3710074-02761678-8060CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762016000600365info:eu-repo/semantics/altIdentifier/url/https://memorias.ioc.fiocruz.br/article/6135/0006_serological-based-monitoring-of-a-cohort-of-patients-with-chronic-chagas-disease-treated-with-benznidazole-in-a-highly-endemic-area-of-northern-argentinainfo:eu-repo/semantics/altIdentifier/doi/10.1590/0074-02760160006info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:58:52Zoai:ri.conicet.gov.ar:11336/114690instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:58:52.858CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern Argentina
title Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern Argentina
spellingShingle Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern Argentina
Niborski, Leticia Laura
ADVERSE EFFECTS
BENZNIDAZOLE TREATMENT
CHRONIC CHAGAS DISEASE
SEROLOGICAL FOLLOW-UP
TRYPANOSOMA CRUZI
title_short Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern Argentina
title_full Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern Argentina
title_fullStr Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern Argentina
title_full_unstemmed Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern Argentina
title_sort Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern Argentina
dc.creator.none.fl_str_mv Niborski, Leticia Laura
Grippo, Vanina
Lafon, Sonia Olga
Levitus, Gabriela Laura
García Bournissen, Facundo
Ramirez Gomez, Juan Carlos
Burgos, Juan Miguel
Bisio, Margarita María Catalina
Juiz, Natalia Anahí
Ayala, Vilma
Coppede, María
Herrera, Verónica
López, Crescencia
Contreras, Ana
Gomez, Karina Andrea
Elean, Juan C.
Mujica, Hugo D.
Schijman, Alejandro Gabriel
Levin, Mariano Jorge
Longhi, Silvia Andrea
author Niborski, Leticia Laura
author_facet Niborski, Leticia Laura
Grippo, Vanina
Lafon, Sonia Olga
Levitus, Gabriela Laura
García Bournissen, Facundo
Ramirez Gomez, Juan Carlos
Burgos, Juan Miguel
Bisio, Margarita María Catalina
Juiz, Natalia Anahí
Ayala, Vilma
Coppede, María
Herrera, Verónica
López, Crescencia
Contreras, Ana
Gomez, Karina Andrea
Elean, Juan C.
Mujica, Hugo D.
Schijman, Alejandro Gabriel
Levin, Mariano Jorge
Longhi, Silvia Andrea
author_role author
author2 Grippo, Vanina
Lafon, Sonia Olga
Levitus, Gabriela Laura
García Bournissen, Facundo
Ramirez Gomez, Juan Carlos
Burgos, Juan Miguel
Bisio, Margarita María Catalina
Juiz, Natalia Anahí
Ayala, Vilma
Coppede, María
Herrera, Verónica
López, Crescencia
Contreras, Ana
Gomez, Karina Andrea
Elean, Juan C.
Mujica, Hugo D.
Schijman, Alejandro Gabriel
Levin, Mariano Jorge
Longhi, Silvia Andrea
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ADVERSE EFFECTS
BENZNIDAZOLE TREATMENT
CHRONIC CHAGAS DISEASE
SEROLOGICAL FOLLOW-UP
TRYPANOSOMA CRUZI
topic ADVERSE EFFECTS
BENZNIDAZOLE TREATMENT
CHRONIC CHAGAS DISEASE
SEROLOGICAL FOLLOW-UP
TRYPANOSOMA CRUZI
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv This study aimed to evaluate well-documented diagnostic antigens, named B13, 1F8 and JL7 recombinant proteins, as potential markers of seroconversion in treated chagasic patients. Prospective study, involving 203 patients treated with benznidazole, was conducted from endemic areas of northern Argentina. Follow-up was possible in 107 out of them and blood samples were taken for serology and PCR assays before and 2, 3, 6, 12, 24 and 36 months after treatment initiation. Reactivity against Trypanosoma cruzi lysate and recombinant antigens was measured by ELISA. The rate of decrease of antibody titers showed nonlinear kinetics with an abrupt drop within the first three months after initiation of treatment for all studied antigens, followed by a plateau displaying a low decay until the end of follow-up. At this point, anti-B13, anti-1F8 and anti-JL7 titers were relatively close to the cut-off line, while anti-T. cruzi antibodies still remained positive. At baseline, 60.8% (45/74) of analysed patients tested positive for parasite DNA by PCR and during the follow-up period in 34 out of 45 positive samples (75.5%) could not be detected T. cruzi DNA. Our results suggest that these antigens might be useful as early markers for monitoring antiparasitic treatment in chronic Chagas disease.
Fil: Niborski, Leticia Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Grippo, Vanina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Lafon, Sonia Olga. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Levitus, Gabriela Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: García Bournissen, Facundo. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Ramirez Gomez, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Burgos, Juan Miguel. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Bisio, Margarita María Catalina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Juiz, Natalia Anahí. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Ayala, Vilma. Centro Asistencial Cáritas Diocesana; Argentina
Fil: Coppede, María. Centro Asistencial Cáritas Diocesana; Argentina
Fil: Herrera, Verónica. Centro Asistencial Cáritas Diocesana; Argentina
Fil: López, Crescencia. Centro Asistencial Cáritas Diocesana; Argentina
Fil: Contreras, Ana. Centro Asistencial Cáritas Diocesana; Argentina
Fil: Gomez, Karina Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Elean, Juan C.. Centro Asistencial Cáritas Diocesana; Argentina
Fil: Mujica, Hugo D.. Centro Asistencial Cáritas Diocesana; Argentina. Hospital Zonal de Añatuya; Argentina
Fil: Schijman, Alejandro Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Levin, Mariano Jorge. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
Fil: Longhi, Silvia Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres"; Argentina
description This study aimed to evaluate well-documented diagnostic antigens, named B13, 1F8 and JL7 recombinant proteins, as potential markers of seroconversion in treated chagasic patients. Prospective study, involving 203 patients treated with benznidazole, was conducted from endemic areas of northern Argentina. Follow-up was possible in 107 out of them and blood samples were taken for serology and PCR assays before and 2, 3, 6, 12, 24 and 36 months after treatment initiation. Reactivity against Trypanosoma cruzi lysate and recombinant antigens was measured by ELISA. The rate of decrease of antibody titers showed nonlinear kinetics with an abrupt drop within the first three months after initiation of treatment for all studied antigens, followed by a plateau displaying a low decay until the end of follow-up. At this point, anti-B13, anti-1F8 and anti-JL7 titers were relatively close to the cut-off line, while anti-T. cruzi antibodies still remained positive. At baseline, 60.8% (45/74) of analysed patients tested positive for parasite DNA by PCR and during the follow-up period in 34 out of 45 positive samples (75.5%) could not be detected T. cruzi DNA. Our results suggest that these antigens might be useful as early markers for monitoring antiparasitic treatment in chronic Chagas disease.
publishDate 2016
dc.date.none.fl_str_mv 2016-06
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/114690
Niborski, Leticia Laura; Grippo, Vanina; Lafon, Sonia Olga; Levitus, Gabriela Laura; García Bournissen, Facundo; et al.; Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern Argentina; Fundação Oswaldo Cruz; Memórias do Instituto Oswaldo Cruz; 111; 6; 6-2016; 365-371
0074-0276
1678-8060
CONICET Digital
CONICET
url http://hdl.handle.net/11336/114690
identifier_str_mv Niborski, Leticia Laura; Grippo, Vanina; Lafon, Sonia Olga; Levitus, Gabriela Laura; García Bournissen, Facundo; et al.; Serological based monitoring of a cohort of patients with chronic chagas disease treated with benznidazole in a highly endemic area of Northern Argentina; Fundação Oswaldo Cruz; Memórias do Instituto Oswaldo Cruz; 111; 6; 6-2016; 365-371
0074-0276
1678-8060
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762016000600365
info:eu-repo/semantics/altIdentifier/url/https://memorias.ioc.fiocruz.br/article/6135/0006_serological-based-monitoring-of-a-cohort-of-patients-with-chronic-chagas-disease-treated-with-benznidazole-in-a-highly-endemic-area-of-northern-argentina
info:eu-repo/semantics/altIdentifier/doi/10.1590/0074-02760160006
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
application/pdf
application/pdf
application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Fundação Oswaldo Cruz
publisher.none.fl_str_mv Fundação Oswaldo Cruz
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613751106437120
score 13.070432